Wednesday, November 25, 2009, 8:17am EST - Canadian Markets open in 1 hour and 13 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Xenacare Holdings Inc. (XCHO.OB)

On Nov 24: 0.079 USD   0.00 (0.00%)  
MORE ON XCHO.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
XENACARE HOLDINGS (OTC BB:XCHO.OB) Delayed quote dataEdit
Last Trade: 0.079 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 0.079
Open: N/A
Bid: 0.078 x 5000
Ask: 0.085 x 5000
1y Target Est: N/A
Day's Range: N/A - N/A
52wk Range: 0.01 - 0.32
Volume: 0
Avg Vol (3m): 449,602
Market Cap: 4.21M
P/E (ttm): N/A
EPS (ttm): -0.037
Div & Yield: N/A (N/A%)
Xenacare Holdings Inc. (XCHO.OB)
1d  5d  3m  6m  1y  2y 
 Add XCHO.OB to Portfolio   Download Data

HEADLINES
XENACARE HOLDINGS, INC. Financials
EDGAR Online Financials (Sat, Nov 21)
XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 16)
XenaCare Holdings Announces Availability of Cobroxin through the Chain Drug Marketing Association (CDMA)
Business Wire (Wed, Nov 4)
XenaCare Holdings Announces Agreement to Market its Over-the-Counter Pain Reliever, Cobroxin, in the Official Annual Publication of NASCAR
Business Wire (Thu, Oct 22)
XenaCare Holdings Announces Agreement to Market OTC Pain Reliever, Cobroxin, in the National Football League (NFL) Alumni Association Publication
Business Wire (Tue, Oct 20)
Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain
Business Wire (Wed, Oct 14)
XENACARE HOLDINGS, INC. Files SEC form 10-Q/A, Quarterly Report
EDGAR Online (Fri, Oct 2)
Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain
Business Wire (Fri, Oct 2)
Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever
Business Wire (Mon, Sep 21)
XenaCare Holdings Announces National Print Advertising Campaign for Cobroxin, a Treatment for Moderate to Severe (Stage 2) Pain
Business Wire (Thu, Sep 3)
More Headlines for XCHO.OB...

BUSINESS SUMMARY
XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of nutrition supplement products primarily in the United States. Its clinical products include XenaCor, which lowers serum cholesterol, C-reactive protein, and homocys...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices